» Articles » PMID: 29143818

Visualization of Chemical Modifications in the Human 80S Ribosome Structure

Overview
Journal Nature
Specialty Science
Date 2017 Nov 17
PMID 29143818
Citations 182
Authors
Affiliations
Soon will be listed here.
Abstract

Chemical modifications of human ribosomal RNA (rRNA) are introduced during biogenesis and have been implicated in the dysregulation of protein synthesis, as is found in cancer and other diseases. However, their role in this phenomenon is unknown. Here we visualize more than 130 individual rRNA modifications in the three-dimensional structure of the human ribosome, explaining their structural and functional roles. In addition to a small number of universally conserved sites, we identify many eukaryote- or human-specific modifications and unique sites that form an extended shell in comparison to bacterial ribosomes, and which stabilize the RNA. Several of the modifications are associated with the binding sites of three ribosome-targeting antibiotics, or are associated with degenerate states in cancer, such as keto alkylations on nucleotide bases reminiscent of specialized ribosomes. This high-resolution structure of the human 80S ribosome paves the way towards understanding the role of epigenetic rRNA modifications in human diseases and suggests new possibilities for designing selective inhibitors and therapeutic drugs.

Citing Articles

Implication of ribosomal protein in abiotic and biotic stress.

Fakih Z, Germain H Planta. 2025; 261(4):85.

PMID: 40067484 DOI: 10.1007/s00425-025-04665-6.


Toward the use of nanopore RNA sequencing technologies in the clinic: challenges and opportunities.

Katopodi X, Begik O, Novoa E Nucleic Acids Res. 2025; 53(5).

PMID: 40057374 PMC: 11890063. DOI: 10.1093/nar/gkaf128.


Specialized ribosomes: integrating new insights and current challenges.

Beavan A, Thuburn V, Fatkhullin B, Cunningham J, Hopes T, Dimascio E Philos Trans R Soc Lond B Biol Sci. 2025; 380(1921):20230377.

PMID: 40045788 PMC: 11883436. DOI: 10.1098/rstb.2023.0377.


Ribosomal protein paralogues in ribosome specialization.

Milenkovic I, Novoa E Philos Trans R Soc Lond B Biol Sci. 2025; 380(1921):20230387.

PMID: 40045786 PMC: 11883438. DOI: 10.1098/rstb.2023.0387.


In situ analysis reveals the TRiC duty cycle and PDCD5 as an open-state cofactor.

Xing H, Rosenkranz R, Rodriguez-Aliaga P, Lee T, Majtner T, Bohm S Nature. 2024; 637(8047):983-990.

PMID: 39663456 PMC: 11754096. DOI: 10.1038/s41586-024-08321-z.


References
1.
Benitez-Paez A, Cardenas-Brito S, Corredor M, Villarroya M, Armengod M . Impairing methylations at ribosome RNA, a point mutation-dependent strategy for aminoglycoside resistance: the rsmG case. Biomedica. 2014; 34 Suppl 1:41-9. DOI: 10.1590/S0120-41572014000500006. View

2.
Gurel G, Blaha G, Moore P, Steitz T . U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome. J Mol Biol. 2009; 389(1):146-56. PMC: 2682339. DOI: 10.1016/j.jmb.2009.04.005. View

3.
Gigova A, Duggimpudi S, Pollex T, Schaefer M, Kos M . A cluster of methylations in the domain IV of 25S rRNA is required for ribosome stability. RNA. 2014; 20(10):1632-44. PMC: 4174444. DOI: 10.1261/rna.043398.113. View

4.
Zorbas C, Nicolas E, Wacheul L, Huvelle E, Heurgue-Hamard V, Lafontaine D . The human 18S rRNA base methyltransferases DIMT1L and WBSCR22-TRMT112 but not rRNA modification are required for ribosome biogenesis. Mol Biol Cell. 2015; 26(11):2080-95. PMC: 4472018. DOI: 10.1091/mbc.E15-02-0073. View

5.
Stojkovic V, Noda-Garcia L, Tawfik D, Fujimori D . Antibiotic resistance evolved via inactivation of a ribosomal RNA methylating enzyme. Nucleic Acids Res. 2016; 44(18):8897-8907. PMC: 5062987. DOI: 10.1093/nar/gkw699. View